Clinical trial · Observational
Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
Prospective Observational Study on Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
NCT05750706CI-TRIAL-00110688SEIFEMcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aims to evaluate incidence of invasive antifungal infections among patients with acute lymphoblastic leukemia Ph negative during the first weeks of treatment
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Lymphoblastic Leukemia, Adult | Adult Acute Lymphoblastic Leukemia | ONTOLOGY_EXACT | 0.98 |
| Invasive Fungal Infections | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| observation of invasive fungal infections | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients without invasive fungal infection
- description
- Acute lymphoblastic leukemia, no invasive fungal infection
- label
- Patients with invasive fungal infection
- description
- Acute lymphoblastic leukemia, invasive fungal infection
- interventionNames
- Other: observation of invasive fungal infections
Primary outcomes (1)
- measure
- Incidence of invasive fungal infections
- timeFrame
- 18 months
- description
- Incidence of invasive fungal infections during first week of chemotherapy
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * diagnosis of acute lymphoblastic leukemia Ph negative * age more than 18 yo Exclusion Criteria: * diagnosis of acute lymphoblastic leukemia Ph positive * acute lymphoblastic leukemia relapsed/refractory * lymphoblastic lymphoma
References
Publications (0)
Data not yet available
No reference posted for this study.